Answers are grounded in this paper and cite their sources.
Abl kinase is a major molecular target for chronic myeloid leukemia therapy. Its activity is tightly controlled by its regulatory module, composed of the SH3 and SH2 domains and the SH2–kinase linker. Although the assembled autoinhibited and extended active conformations have been structurally characterized, the molecular pathway connecting these states remains poorly understood. Simulations initiated from the end point structures failed to sample the complete transition, even when Gaussian accelerated molecular dynamics (GaMD) was employed to enhance conformational sampling. To overcome this limitation, we combined multiscale modeling with extensive molecular dynamics simulations and Markov state modeling to reconstruct the Abl disassembly pathway. The resulting kinetic landscape revealed two coupled conformational equilibria: a faster exchange between the canonical assembled state and an intermediate ensemble that captures the initial rotation of the regulatory module, and a slower transition toward the extended state, characterized by migration of the regulatory module atop the kinase domain N-lobe. The assembled ensemble is favored (∼88% of the equilibrium population), with the canonical autoinhibited arrangement alone accounting for approximately 60%, while early disassembly disrupts the E98–K294 and SH3–linker interactions and releases Y226 from its protective interactions, while Y70 remains accessible through the intrinsic dynamics of the SH3 domain. By revealing how these phosphorylation-sensitive residues become accessible during the earliest stages of disassembly, our model provides a mechanistic framework for Abl activation and identifies regulatory interfaces as potential targets for allosteric stabilization of the autoinhibited state.
No takes yet. Share an insight, caveat, or question.
Fernandes et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: